Thetis Pharmaceuticals

About:

Thetis Pharmaceuticals is a biopharmaceutical company.

Top Investors: Connecticut Innovations, National Institutes of Health, Stonehenge Capital, River Valley Investors, The Leona M. and Harry B. Helmsley Charitable Trust

Description:

Thetis Pharmaceuticals LLC is a biopharmaceutical company developing novel small molecule drugs to treat inflammatory diseases.

Total Funding Amount:

$22.9M

Estimated Revenue Range:

Less than $1M

Headquarters Location:

Ridgefield, Connecticut, United States

Founded Date:

2011-01-01

Contact Email:

info(AT)thetispharma.com

Founders:

Frank Sciavolino, Gary Mathias

Number of Employees:

1-10

Last Funding Date:

2022-04-05

IPO Status:

Private

Industries: